Iron, brain ageing and neurodegenerative disorders

Luigi Zecca, Moussa B.H. Youdim, Peter Riederer, James Connor, Robert R. Crichton

Research output: Contribution to journalReview article

1147 Citations (Scopus)

Abstract

There is increasing evidence that iron is involved in the mechanisms that underlie many neurodegenerative diseases. Conditions such as neuroferritinopathy and Friedreich ataxia are associated with mutations in genes that encode proteins that are involved in iron metabolism, and as the brain ages, iron accumulates in regions that are affected by Alzheimer's disease and Parkinson's disease. High concentrations of reactive iron can increase oxidative-stress induced neuronal vulnerability, and iron accumulation might increase the toxicity of environmental or endogenous toxins. By studying the accumulation and cellular distribution of iron during ageing, we should be able to increase our understanding of these neurodegenerative disorders and develop new therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)863-873
Number of pages11
JournalNature Reviews Neuroscience
Volume5
Issue number11
DOIs
StatePublished - Nov 1 2004

Fingerprint

Brain Diseases
Neurodegenerative Diseases
Iron
Friedreich Ataxia
Parkinson Disease
Alzheimer Disease
Oxidative Stress
Mutation
Brain
Proteins

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J., & Crichton, R. R. (2004). Iron, brain ageing and neurodegenerative disorders. Nature Reviews Neuroscience, 5(11), 863-873. https://doi.org/10.1038/nrn1537
Zecca, Luigi ; Youdim, Moussa B.H. ; Riederer, Peter ; Connor, James ; Crichton, Robert R. / Iron, brain ageing and neurodegenerative disorders. In: Nature Reviews Neuroscience. 2004 ; Vol. 5, No. 11. pp. 863-873.
@article{3885056669eb496e995a7453c14750b8,
title = "Iron, brain ageing and neurodegenerative disorders",
abstract = "There is increasing evidence that iron is involved in the mechanisms that underlie many neurodegenerative diseases. Conditions such as neuroferritinopathy and Friedreich ataxia are associated with mutations in genes that encode proteins that are involved in iron metabolism, and as the brain ages, iron accumulates in regions that are affected by Alzheimer's disease and Parkinson's disease. High concentrations of reactive iron can increase oxidative-stress induced neuronal vulnerability, and iron accumulation might increase the toxicity of environmental or endogenous toxins. By studying the accumulation and cellular distribution of iron during ageing, we should be able to increase our understanding of these neurodegenerative disorders and develop new therapeutic strategies.",
author = "Luigi Zecca and Youdim, {Moussa B.H.} and Peter Riederer and James Connor and Crichton, {Robert R.}",
year = "2004",
month = "11",
day = "1",
doi = "10.1038/nrn1537",
language = "English (US)",
volume = "5",
pages = "863--873",
journal = "Nature Reviews Neuroscience",
issn = "1471-003X",
publisher = "Nature Publishing Group",
number = "11",

}

Zecca, L, Youdim, MBH, Riederer, P, Connor, J & Crichton, RR 2004, 'Iron, brain ageing and neurodegenerative disorders', Nature Reviews Neuroscience, vol. 5, no. 11, pp. 863-873. https://doi.org/10.1038/nrn1537

Iron, brain ageing and neurodegenerative disorders. / Zecca, Luigi; Youdim, Moussa B.H.; Riederer, Peter; Connor, James; Crichton, Robert R.

In: Nature Reviews Neuroscience, Vol. 5, No. 11, 01.11.2004, p. 863-873.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Iron, brain ageing and neurodegenerative disorders

AU - Zecca, Luigi

AU - Youdim, Moussa B.H.

AU - Riederer, Peter

AU - Connor, James

AU - Crichton, Robert R.

PY - 2004/11/1

Y1 - 2004/11/1

N2 - There is increasing evidence that iron is involved in the mechanisms that underlie many neurodegenerative diseases. Conditions such as neuroferritinopathy and Friedreich ataxia are associated with mutations in genes that encode proteins that are involved in iron metabolism, and as the brain ages, iron accumulates in regions that are affected by Alzheimer's disease and Parkinson's disease. High concentrations of reactive iron can increase oxidative-stress induced neuronal vulnerability, and iron accumulation might increase the toxicity of environmental or endogenous toxins. By studying the accumulation and cellular distribution of iron during ageing, we should be able to increase our understanding of these neurodegenerative disorders and develop new therapeutic strategies.

AB - There is increasing evidence that iron is involved in the mechanisms that underlie many neurodegenerative diseases. Conditions such as neuroferritinopathy and Friedreich ataxia are associated with mutations in genes that encode proteins that are involved in iron metabolism, and as the brain ages, iron accumulates in regions that are affected by Alzheimer's disease and Parkinson's disease. High concentrations of reactive iron can increase oxidative-stress induced neuronal vulnerability, and iron accumulation might increase the toxicity of environmental or endogenous toxins. By studying the accumulation and cellular distribution of iron during ageing, we should be able to increase our understanding of these neurodegenerative disorders and develop new therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=8344265251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8344265251&partnerID=8YFLogxK

U2 - 10.1038/nrn1537

DO - 10.1038/nrn1537

M3 - Review article

C2 - 15496864

AN - SCOPUS:8344265251

VL - 5

SP - 863

EP - 873

JO - Nature Reviews Neuroscience

JF - Nature Reviews Neuroscience

SN - 1471-003X

IS - 11

ER -